Avoiding transfusions in children undergoing cardiac surgery: A meta-analysis of randomized trials of aprotinin

Anesthesia and Analgesia

Volumn 102, Issue 3, 2006, Pages 731-737

  Arnold, Donald M ^a   Fergusson, Dean A ^b   Chan, Anthony K C ^a   Cook, Richard J ^c   Fraser, Graeme A ^a,d   Lim, Wendy ^a   Blajchman, Morris A ^a   Cook, Deborah J ^a,e  

^a MCMASTER UNIVERSITY   (Canada)

^b UNIVERSITY OF OTTAWA   (Canada)

^c UNIVERSITY OF WATERLOO   (Canada)

^d JURAVINSKI CANCER CENTRE   (Canada)

^e MCMASTER UNIVERSITY MEDICAL CENTRE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFIBRINOLYTIC AGENT; APROTININ;

ARTICLE; BLOOD TRANSFUSION; BLOOD VOLUME; CARDIOPULMONARY BYPASS; CLINICAL TRIAL; ERYTHROCYTE; HEART SURGERY; HUMAN; META ANALYSIS; PALLIATIVE THERAPY; PLASTIC SURGERY; PRIORITY JOURNAL; QUALITY CONTROL; SYSTEMATIC REVIEW; THORAX DRAINAGE;

EID: 33644534151     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/01.ane.0000194954.64293.61     Document Type: Article

References (32)

1. Levy JH, Tanaka KA. Inflammatory response to cardiopulmonary bypass. Ann Thorac Surg 2003;75:S715-20.
2. Davies LK. Cardiopulmonary bypass in infants and children: how is it different? J Cardiothorac Vasc Anesth 1999;13:330-45.
3. Lavee J, Savion N, Smolinsky A, et al Platelet protection by aprotinin in cardiopulmonary bypass: electron microscopic study. Ann Thorac Surg 1992;53:477-81.
4. Bidstrup BP, Harrison J, Royston D, et al Aprotinin therapy in cardiac operations: a report on use in 41 cardiac centers in the United Kingdom. Ann Thorac Surg 1993;55:971-6.
5. Dietrich W, Barankay A, Hahnel C, Richter JA. High-dose aprotinin in cardiac surgery, three years' experience in 1,784 patients. J Cardiothorac Vasc Anesth 1992;6:324-7.
6. Parolari A, Antona C, Gerometta P, et al The effect of "high dose" aprotinin and other factors on bleeding and revisions for bleeding in adult coronary and valve operations: an analysis of 2190 patients during a five-year period (1987-1991). Eur J Cardiothorac Surg 1995;9:77-82.
7. Levi M, Cromheecke ME, de Jonge E, et al Pharmacological strategies to decrease excessive blood loss in cardiac surgery: a meta-analysis of clinically relevant endpoints. Lancet 1999;354:1940-7.
8. Faught C, Wells P, Fergusson D, Laupacis A. Adverse effects of methods for minimizing perioperative allogeneic transfusion: a critical review of the literature. Transfus Med Rev 1998;12:206-25.
9. Henry DA, Moxey AJ, Carless PA, et al Anti-fibrinolytic use for minimizing perioperative allogeneic blood transfusion. Cochrane Review 2004;(1):CD001886.
10. Sedrakyan A, Treasure T, Elefteriades JA. Effect of aprotinin on clinical outcomes in coronary artery bypass graft surgery: a systematic review and meta-analysis of randomized clinical trials. J Thorac Cardiovasc Surg 2004;128:442-8.
11. Dickersin K, Scherer R, Lefebvre C. Identifying relevant studies for systematic reviews. BMJ 1994;309:1286-91.
12. Mossinger H, Dietrich W, Braun SL, et al High-dose aprotinin reduces activation of hemostasis, allogeneic blood requirement, and duration of postoperative ventilation in pediatric cardiac surgery. Ann Thorac Surg 2003;75:430-7.
13. Boldt J, Knothe C, Zickmann B, et al Aprotinin in pediatric cardiac operations: platelet function, blood loss, and use of homologous blood. Ann Thorac Surg 1993;55:1460-6.
14. Jadad AR, Moore RA, Carroll D, et al Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 1996;17:1-12.
15. DerSimonian R, Laird N. Metaanalysis in Clinical-Trials. Control Clin Trials 1986;7:177-88.
16. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003;327:557-60.
17. Clark HD, Wells GA, Huet C, et al Assessing the quality of randomized trials: reliability of the Jadad scale. Control Clin Trials 1999;20:448-52.
18. Boldt J, Knothe C, Zickmann B, et al Comparison of two aprotinin dosage regimens in pediatric patients having cardiac operations. Influence on platelet function and blood loss. J Thorac Cardiovasc Surg 1993;105:705-11.
19. Boldt J, Zickmann B, Schindler E, et al Influence of aprotinin on the thrombomodulin/protein C system in pediatric cardiac operations. J Thorac Cardiovasc Surg 1994;107:1215-21.
20. Chauhan S, Kumar BA, Rao BH, et al Efficacy of aprotinin, epsilon aminocaproic acid, or combination in cyanotic heart disease. Ann Thorac Surg 2000;70:1308-12.
21. D'Errico CC, Shayevitz JR, Martindale SJ, et al The efficacy and cost of aprotinin in children undergoing reoperative open heart surgery. Anesth Analg 1996;83:1193-9.
22. Davies MJ, Allen A, Kort H, et al Prospective, randomized, double-blind study of high-dose aprotinin in pediatric cardiac operations. Ann Thorac Surg 1997;63:497-503.
23. Herynkopf F, Lucchese F, Pereira E, et al Aprotinin in children undergoing correction of congenital heart defects: a double-blind pilot study. J Thorac Cardiovasc Surg 1994;108:517-21.
24. Miller BE, Tosone SR, Tam VK, et al Hematologic and economic impact of aprotinin in reoperative pediatric cardiac operations. Ann Thorac Surg 1998;66:535-40.
25. Seghaye MC, Duchateau J, Grabitz RG, et al Influence of low-dose aprotinin on the inflammatory reaction due to cardiopulmonary bypass in children. Ann Thorac Surg 1996;61:1205-11.
26. Dietrich W, Mossinger H, Spannagl M, et al Hemostatic activation during cardiopulmonary bypass with different aprotinin dosages in pediatric patients having cardiac operations. J Thorac Cardiovasc Surg 1993;105:712-20.
27. Gomar C, del Pozo D, Fita G, et al Aprotinin in paediatric cardiac surgery: blood loss and use of blood products. Br J Anaesthesia 1995;74:33.
28. Coniff RF. The Bayer 022 compassionate-use pediatric study. Ann Thorac Surg 1998;65:S31-3.
29. Kern FH, Morana NJ, Sears JJ, Hickey PR. Coagulation defects in neonates during cardiopulmonary bypass. Ann Thorac Surg 1992;54:541-6.
30. Lemmer JH Jr. Reporting the results of blood conservation studies: the need for uniform and comprehensive methods. Ann Thorac Surg 1994;58:1305-6.
31. Bhandari M, Busse JW, Jackowski D, et al Association between industry funding and statistically significant pro-industry findings in medical and surgical randomized trials. CMAJ 2004;170:477-80.
32. Monagle P, Chan A, Massicotte P, et al Antithrombotic therapy in children: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004;126:645S-87S.